Sec. 2. Consistent with standard medical practices in pain management treatment, the medical licensing board shall adopt rules under IC 4-22-2 to establish standards and protocols for the prescribing of controlled substances, including the use of abuse deterrent formulations.
As added by P.L.185-2013, SEC.3. Amended by P.L.54-2015, SEC.1.